Predictive Subgroup/Biomarker Identification and Machine Learning Methods

M. Man (), T. S. Nguyen, C. Battioui and G. Mi ()
Additional contact information
M. Man: Eli Lilly and Company
T. S. Nguyen: Nektar Therapeutics
C. Battioui: Eli Lilly and Company
G. Mi: Eli Lilly and Company

A chapter in Statistical Methods in Biomarker and Early Clinical Development, 2019, pp 1-22 from Springer

Abstract: Abstract Precision medicine or patient tailoring is very important for drug development due to its potential of increasing efficacy and/or reducing adverse reaction for the right patients (with genomic or other types of biomarker). The next two chapters will discuss statistical methods pertinent to biomarkers that are the important ingredient in developing precision medicine.

Date: 2019
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-030-31503-0_1

Ordering information: This item can be ordered from
http://www.springer.com/9783030315030

DOI: 10.1007/978-3-030-31503-0_1

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().